Animal Assisted Thearpy (AAT) at an university palliative care centre:A qualitative interview study to verify the therapeutic effect of Animal Assisted Therapy from the perspective of patients and its feasibility
Completed
- Conditions
- ANGST BEI PALLIATIVPATIENTE
- Registration Number
- DRKS00007108
- Lead Sponsor
- Interdisziplinäres Zentrum für Palliativmedizin (IZP)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 21
Inclusion Criteria
palliative patients in IZP, with an indication for AAT
- min. 18 years old
- ability to participate in an interview (cognitive and linguistic skills)
- written informed consent
Exclusion Criteria
- Allergy of the coat of Dogs
- Canophobic patients
-Infections caused by multiresistant pathogens
- Disability to participate in an interwiew
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Detection, what palliative patients feel at AAT, what is their sense of it, evaluate feasibility, to confirm the indication for this therapy and to record their needs and their requirements related to AAT. Doing qualitative interviews, based on an interview guide, not later than 24 hours after their first AAT
- Secondary Outcome Measures
Name Time Method Detection of psychosocial stress with the Distress Thermometer 1. when the patient admitted, bevor first AAT, 2. in process
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the therapeutic effects of Animal Assisted Therapy in palliative care settings?
How does Animal Assisted Therapy compare to standard-of-care interventions for anxiety in palliative patients?
Are there specific biomarkers that predict patient response to Animal Assisted Therapy in palliative care?
What are the potential adverse events associated with Animal Assisted Therapy in palliative care and how are they managed?
What combination approaches or alternative therapies are being explored alongside Animal Assisted Therapy for palliative anxiety management?